Post di Techniconsult Group

Gli affari regolatori sono cruciali per garantire la sicurezza e la conformità dei prodotti nel settore biomedico. 💊 🔬 ➡ Come si gestiscono le complessità di questo ambito? Lo abbiamo chiesto ad Antonia, Regulatory Affairs Consultant nella divisione Life Sciences in ALTEN Italia. Leggi l’intervista per scoprire il suo ruolo e le sue strategie vincenti! 👇 #ALTENItalia #RegulatoryAffairs #LifeSciences

🎉 Celebrating a Breakthrough in Product Quality through Pharma Analytics! 🌟🔬 🔍 The Challenge: Ensuring impeccable product quality amidst stringent regulations and evolving market demands was our uphill battle. Traditional quality assurance methods weren't enough to keep pace with the industry's dynamic landscape. 💡 Our Solution: Harnessing advanced analytics tools, we delved deep into data streams across the manufacturing process, from raw materials to finished products. By deploying predictive modeling and real-time monitoring, we identified potential quality issues before they arose, enabling proactive interventions. 🚀 The Outcome: Our analytics-driven approach delivered remarkable outcomes: ✅ Enhanced production efficiency while maintaining stringent quality standards ✅ Timely identification and mitigation of potential quality deviations ✅ Improved customer satisfaction and trust through consistent quality delivery 🙌 Kudos to our dedicated team whose collaborative efforts and commitment to excellence made this achievement possible. It's a testament to the transformative power of analytics in redefining product quality standards within the Pharma sector. 🌟 Key Takeaways: 1️⃣ Embrace analytics as a proactive tool for quality assurance. 2️⃣ Foster a culture of continuous improvement and data-driven decision-making. 3️⃣ Leverage technology to stay ahead in ensuring product excellence. 🤝 Join us in celebrating this milestone and advocating for elevated product quality standards through analytics-driven innovation in Pharma! #ProductQuality #AnalyticsInPharma #Innovation #QualityAssurance #DataDrivenDecisions #SuccessStory #TransformativeAnalytics SDG Group Italy #cloud #Management #data #technology #Analytics SDG Group Luca Bergamini Edoardo Bellio Marco Mobilio Elena Massaro Riccardo Paolini Vincenzo Genchi

Il panorama del settore farmaceutico è in continua evoluzione. 💊 Dalle ultime scoperte scientifiche alle nuove dinamiche legate alla supply chain, sono solo alcuni dei fattori esterni che impongono cambiamenti continui alle aziende del settore che devono adattarsi in maniera efficace ed efficiente. 🗓️ Ne parlaremo nel webinar "Il Technology Transfer nel settore farmaceutico" del 14 marzo insieme a Deborah V., Elisa Casiraghi, Gaetano Lopopolo, Giorgio Di Eleonora. Vuoi saperne di più? Leggi il nostro articolo su NCF - Notiziario Chimico Farmaceutico qui 👉https://lnkd.in/dTmizmVe 👇 E iscriviti al nostro #webinar! #SmarterFuture #LifeScience #Pharma #TechnologyTransfer

"Companies are always looking for ways to improve their bottom line, and often, workforce reduction is an immediate go-to solution as a first step. While reducing the workforce can relieve short term pressures, at TriRadial we believe theres's a better way to address near term cost concerns while helping to ensure long term success." Geoff Garabedian outlines 3 key areas to optimize cost and improve performance. Want to know more? Contact us at info@triradial.com #changemanagement #performance #transformation #TriRadial #biopharma #lifesciences #consulting #growth

📢 EKF Diagnostics (#EKF) announces its unaudited interim results for the six months ended 30 June 2024 (H1 2024). 💪 Strong improvement in gross margins, earnings growth and cash generation, in-line with management expectations. 🗣 Julian Baines MBE, Executive Chair of EKF, commented: “The Board remains confident in the outlook for the business overall and with orders already in house for the second half we are very confident that the Point of Care performance in Europe, Middle East and Africa will improve significantly. The actions we’ve taken are expected to yield further improvements in gross margins, earnings growth and cash generation, and as a result of our efficiency drive we now have a leaner business, with a cost base correctly aligned to a more focused higher-margin product mix. “The Company expects the improvement in performance to continue in H2 2024 and remains confident that full year results will be in-line with market expectations.” 🎥 Investor Presentation will be held on Wednesday 18 September 2024 at 4.30pm (BST), via the Investor Meet Company. 🔗 https://lnkd.in/e5r3XsHp

Un interessante webinar gratuito da non perdere! #akkodis #lifescience

On the heels of #Asembia24 and #ISMPPAnnual2024, our @Envision Pharma Group team didn’t slow down in the slightest! Last week, our team spent time leading the conversation about the importance of Health Economics and Opportunity Research at #ISPOR2024 in our evolving landscape. With a global emphasis on making life sciences products and therapies more accessible and specialized, HEOR studies will play an outsized role in validating their effectiveness, leading to greater market access and success. Whether you're introducing a new generic or an entirely new drug, having a HEOR expert overlooking your research and market strategies is invaluable. 

Il Lean e il Value Based e un board formato dai principali esperti e stakeholder di 12 regioni per migliorare l’accesso al farmaco ed alle cure questo è il Lean4farma!

At TH Healthcare & Life Sciences we are excited to present our research report: Global Life Sciences Outsourcing: Targeting the USD 425 Billion CRO and CDMO Opportunity Download this exclusive report to gain valuable highlights on: ▪️ Driving Market Trends: Explore essential developments fueling progress in the CDMO and CRO sectors ▪️ Comprehensive Services Overview: Examine the breadth of services integral to the drug development process ▪️ Analysis of EBITDA Multiples: Review the sector’s financial health through EV/EBITDA ratios against the S&P 500, assessing its investment potential ▪️ Focused M&A Insights: Detailing M&A drivers, our report spotlights the M&A activity reshaping the life sciences outsourcing landscape You can download the full research report here: https://lnkd.in/d5BnDgDK Vivek Subramanyam, Geeta Ramanathan, CFA, Asif Shahinsha, Anant Kharad, Tim Sturgeon #Report #CRO #CDMO #LifeSciences #Healthcare #MergersandAcquisitions #PrivateEquity #InvestmentBanking #thhealthcare

📢 Unitevi a noi per il webinar della serie Project Pharma Talks: Pharma Shutdown Program (SDP) 📆 30 Aprile 2024 ⏰ Ore 18.30 👉 Iscriviti https://bit.ly/3TWdbmx 👨💼 Fabio Degl’Innocenti di ERsistemi SPA condividerà preziosi insight sul ruolo cruciale del Program Management nei shutdown dell'industria chimico-farmaceutica. 🔍 Scopri come ottimizzare l'efficienza e ridurre i tempi di inattività durante gli shutdown, rispettando le rigide normative del settore come la conformità GMP. 💡 Approfondiremo l'importanza dell'automazione industriale e esploreremo casi di studio reali per illustrare miglioramenti significativi nella gestione degli shutdown. Non perdere l'occasione di arricchire le tue conoscenze! Iscriviti ora! #PMI #PMICI #PharmaIndustry #ProjectManagement #Webinar 🚀🔬